Does TOFACITINIB Cause Hypokalaemia? 194 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Hypokalaemia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
194
Reports of Hypokalaemia with TOFACITINIB
0.1%
of all TOFACITINIB reports
17
Deaths
176
Hospitalizations
How Dangerous Is Hypokalaemia From TOFACITINIB?
Of the 194 reports, 17 (8.8%) resulted in death, 176 (90.7%) required hospitalization, and 56 (28.9%) were considered life-threatening.
Is Hypokalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 194 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Hypokalaemia?
FUROSEMIDE (2,503)
HYDROCHLOROTHIAZIDE (1,152)
CARBOPLATIN (1,118)
PREDNISONE (967)
DEXAMETHASONE (876)
CYCLOPHOSPHAMIDE (864)
OMEPRAZOLE (851)
RITUXIMAB (822)
AMLODIPINE (815)
PANTOPRAZOLE (811)
Which TOFACITINIB Alternatives Have Lower Hypokalaemia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN